Literature DB >> 4068005

Dopamine receptor agonist activity of some 5-(2-aminoethyl)carbostyril derivatives.

C Kaiser, P A Dandridge, E Garvey, K E Flaim, R L Zeid, J P Hieble.   

Abstract

The potency of beta-adrenoreceptor agonists, e.g., isoproterenol, is strikingly increased by substitution of the meta catecholic hydroxyl group with the NH group of a carbostyril system. To explore the possibility that comparable potency enhancement might occur upon similar modification of the catechol ring of dopamine, a series of 5-(2-aminoethyl)carbostyril derivatives was prepared and examined for D-1 and D-2 dopamine receptor-stimulating activity. Only the parent compound, 5-(2-aminoethyl)-8-hydroxycarbostyril (2), produced measurable activation of dopamine-sensitive adenylate cyclase (29% at a concentration of 10 microM). Some of the compounds, however, did produce significant activity in tests, namely displacement of [3H]spiroperidol binding from bovine pituitary homogenate and an isolated perfused rabbit ear artery preparation, that measure interaction with D-2 receptors. Potency of the carbostyrils was enhanced by 8-hydroxylation and by appropriate substitution of the amino group of the ethylamine side chain. The most potent member of the series was 8-hydroxy-5-[2-[[2-(4-hydroxyphenyl)ethyl]-n-propylamino]ethyl] carbostyril (16b). This compound was about 3 times more effective than dopamine in the D-2 receptor tests. Clearly, the results of this study indicate that potency of dopamine receptor agonists is not increased by carbostyril replacement of the m-hydroxyl as is noted with the beta-adrenergic receptor agonists.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4068005     DOI: 10.1021/jm00150a010

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  1 in total

1.  Photocytotoxicity of the fluorescent nonsteroidal androgen receptor ligand TDPQ.

Authors:  Piotr J Bilski; Boris Risek; Colin F Chignell; William T Schrader
Journal:  Photochem Photobiol       Date:  2009-05-28       Impact factor: 3.421

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.